US20030138871A1 - Method of analysing a sample of free cells - Google Patents

Method of analysing a sample of free cells Download PDF

Info

Publication number
US20030138871A1
US20030138871A1 US10/329,608 US32960802A US2003138871A1 US 20030138871 A1 US20030138871 A1 US 20030138871A1 US 32960802 A US32960802 A US 32960802A US 2003138871 A1 US2003138871 A1 US 2003138871A1
Authority
US
United States
Prior art keywords
suspension
sample
platelets
cell
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/329,608
Inventor
Ian Shine
Thomas Shine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828765.9A external-priority patent/GB9828765D0/en
Priority claimed from GBGB9910266.7A external-priority patent/GB9910266D0/en
Priority claimed from GBGB9910267.5A external-priority patent/GB9910267D0/en
Application filed by Individual filed Critical Individual
Priority to US10/329,608 priority Critical patent/US20030138871A1/en
Publication of US20030138871A1 publication Critical patent/US20030138871A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G01N13/04Investigating osmotic effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • G01N2015/1024
    • G01N2015/1029

Definitions

  • the present invention relates to a method of analysing a sample of free cells, in particular blood cells.
  • a method of determining a measure of the number of platelets in a cell suspension containing platelets comprising the steps of: counting the number of small particles in the suspension; agitating the suspension in the presence of a gas; counting the number of small particles in the suspension after agitation; and comparing the two counts to obtain a measure of the number of platelets.
  • the method of the invention differentiates platelets from other small particles exploiting a simple physiological property and removes spuriously low automated platelet counts.
  • the accurate measurement of platelet number and function is of great consequence to a patient's health. Aside from bleeding to death from thrombocytopenia (insufficient platelets), platelets are risk components of strokes, heart attacks, and inflammation, and are important elements in the growth of epithelial malignancies and metastases.
  • WO 97/24598, WO 97/24599 and WO 97/24601 provide a way to measure the size, shape, and number of particles while the particles are simultaneously exposed to a variety of osmotic gradients.
  • further information may be derived from this test by combining it with the present invention. For example, by testing a whole blood suspension under osmotic stress, and comparing the results to the same sample after mechanical agitation in the presence of air, the components of the sample population which are altered by mechanical agitation in the presence of air can be determined.
  • the types and proportion of each type can be revealed in a single procedure.
  • red cells, white cells, micro-spherocytes, and bacteria are uninfluenced by me agitation in the presence of air whereas platelets alone disappear.
  • the advantage of this method is that in addition to explaining a way to differentiate and count platelets, it offers existing instruments a very simple method of increasing the accuracy of their counts.
  • This process of inducing the nature of these small particles can be likened to the identification of an unknown fluid by raising its temperature; if it boils at 78° C. it is ethyl alcohol, if it boils at 100° C. it is water and at 357° C. it is mercury.
  • the small particles counted in the method of the invention include platelets, bacteria, cell fragments, and micro-spherocytes, which typically have a volume of 7-10 femtolitres.
  • a method of analysing a sample of free cells in vitro comprises applying a known or identifiable quantity of stress to the sample, measuring the sample before and after the application of stress to provide at least one reading from which quantitative information relating to the number of cell fragments in the sample caused by the applied stress can be determined, and relating this reading to the quantity of stress to provide an indication of cell friability.
  • red cells When red cells die, they lose their contents, a process termed lysis. They are then transformed into either ghost cells or fragments depending, in part, on the cell's membrane properties, and in part on the provocation. Hitherto, this mechanism has been little recognised or understood.
  • the present invention is based on the realisation that if cells, such as blood cells, and in particular red cells, are stressed in vitro the relationship between the applied stress and fragmentation to the sample is characteristic for normal samples and for many diseases. Since some cells (platelets) produce no detectable fragments and some (red cells) produce a large number this method also provides a way of distinguishing between certain cell types.
  • the method of the present invention has been found to be remarkably good at identifying certain blood abnormalities because it detects patients whose cells fragment when stressed. Because applied stress affects red blood cell fragments and platelets differently, it is possible to distinguish between the two. This has not been possible in the prior art-particle counters because platelets and red blood cells fragments are usually not measured individually. In addition, as a sample can be tested before, during and after a stress has been applied, the induced effect provides an indication of the physiological fragmentation potential and the physiological removal rate.
  • the invention can be used to identify the age of population of cells since old cells fragment readily whereas new ones do not fragment readily. This may be useful in blood-banking, for instance, to destroy selectively a particular population of cells using a particular range of stresses, thereby prolonging the life of the unit by culling the old cells.
  • the applied stress can be mechanical, chemical, thermal, sonic, light, electric, electromagnetic, or any other means which induces membrane stress including in vitro aging of the cell sample.
  • the cells are subjected to an osmotic gradient. They may also be agitated by a stirring bar, by shaking vigorously, or by any other type of stress. More than one stress mechanism can be used at the same time if necessary. Indeed this may be beneficial in identifying certain abnormalities.
  • a known stress and more preferable to apply a range of stresses, which may be decreasing or haphazard, but is preferably increasing, so as to obtain a plot of the relationship between the number of red blood cell fragments and the applied stress.
  • This range of stresses can be applied by varying duration and/or intensity, for example, by virtue of mechanically agitating the sample increasingly vigorously, by mechanically agitating the sample at a constant rate over an increasing period of time, by diluting the sample with a solution which gradually decreases in osmolality, or by any combination of these mechanisms.
  • the latter approach can be carried out using the apparatus disclosed in WO 97/24529, which generates an osmolality gradient.
  • Characteristics providing the quantative information relating to the number of cell fragments include the detection of the fragments themselves, an alteration in the frequency distributions of multiple cell populations, an increase in the total particle count, a change in the concentration of intact cells, a change in the concentration of membrane or cytosolic parts, such as haemoglobin release, or other such phenomena related to induced cell fragmentation.
  • the step of counting the number of small particles is preferably done using a conventional commercially available particle counter, or using the apparatus disclosed in WO 97/24600.
  • the blood sample is caused to flow through a sensor, typically an aperture, where its size is detected optically, acoustically, thermally, electronically or by other means.
  • a sensor typically an aperture
  • the response of the electrical field to the passage of the cells is recorded as a series of voltage pulses, the amplitude of each pulse being a function of cell fragment size and frequency.
  • WO 97/24598, WO 97/24599 and WO 97/24601 When a stress has been applied to a blood sample, as for example, in WO 97/24598, WO 97/24599 and WO 97/24601, it was performed to obtain accurate volume and other cell measurements by forcing cells to a known shape.
  • the method disclosed herein induces cells to fragment and measures the result of fragmentation. This may be enhanced by, for instance, eliminating all particles except for the fragments of interest by setting the upper and lower threshold voltages to the size range of fragments, by facilitating fragmentation by applying heparin or other suitable chemicals in the chemical preparation of the sample and/or by allowing sufficient time for fragmentation to proceed.
  • the induction, detection and quantification of fragments enhances the measures produced by WO 97/24598, WO 97/24599 and WO 97/24601 and other measures which may be altered by induced or existing fragments.
  • the thresholds should be set low enough to detect cells down to a volume of almost 0 femtolitres.
  • a threshold voltage of 0.08 mV has been found to work well with the existing apparatus.
  • Other populations of particles may be eliminated electronically, digitally, mechanically, or by other means.
  • FIGS. 1 to 5 are frequency distributions indicating the profile of cell size measurement against increasing osmotic and mechanical stress for a number of cell samples.
  • FIGS. 1 to 5 of the accompanying drawings are frequency distributions indicating the profile of the cell size measurement against increasing stress for a sample of cells tested using the apparatus disclosed in WO 97/24529 and the electrode disclosed in WO 97/24600.
  • Such frequency distributions have previously been used, for example in WO 97/24598, WO 97/24599, and WO 97/24601, for example to provide indications of the cell permeability, osmolality and cell shape respectively of normal unfragmented red blood cells.
  • FIG. 1 is a blood sample from a healthy person. As the stress is increased from point A onwards, the cells begin to swell resulting in the gradual increase in mean cell size. At a certain osmolality the cell size can increase no more, and upon a further increase-in stress, the cells evacuate their contents to become “ghost cells” as shown at region B. These characteristics of cells yield diagnostic information which is useful alongside the techniques of the present invention. However, the present invention is unconcerned with these characteristics and is independent of them, but is instead concerned with the cells which appear along the baseline of the graph of FIG. 1. The nature of these small baseline cells can be differentiated by their distribution against osmotic stress, their distribution against mechanical stress and/or their response to contact with air.
  • Platelets are uninfluenced by osmotic stress within the range tested (300-100 mOsm/Kg). However, fragments are strongly influenced by osmotic stress. They rarely appear without the provocation of lysis and become more numerous as lysis increases. Thus fragments vary inversely with osmolality. Mechanical stress has opposing effects on platelets and fragments, an influence that is intensified by concomitant exposure to air. It provokes the appearance of fragments but it induces the lysis of platelets rendering them invisible.
  • FIGS. 2 A-F demonstrate that platelets are rendered invisible with progressive agitation in air (with respective agitation periods of 0, 1, 2, 6, 10 and 15 seconds).
  • the signal along the base line in FIG. 2A is attributable to the presence of platelets since their frequency is approximately the same at all osmolalites, and since even 2 seconds of agitation in air induces almost complete disappearance (see FIG. 2C).
  • the phenomenon cannot be attributed to platelet attachment to the red cells or white cells (satelitism) since FIGS. 3 A-F shows the same phenomenon in a pure platelet suspension when no other cells types are present.
  • FIGS. 4 A-E demonstrate the effect of mechanical agitation in air with time. As the agitation period proceeds going from 4 A down to 4 E the number of fragments generated increases. At the same time, platelets are rapidly made invisible (although it is difficult to see this in these particular Figures).
  • FIGS. 5 A-D demonstrate the platelet reduction in a whole blood sample on shaking with air. Such frequency distributions have previously been used, for example, in WO 97/24598, WO 97/24599, WO 97/24601.
  • the preferred method comprises measuring platelets, using existing automated particle counters, mixing and testing the sample in the absence of air. If some air is unavoidable, the surface area of the samples meniscus should be minimized to limit the effect on the sample or alternatively a gas which has no effect on the platelets should be used. This single measurement will provide an accurate count for all samples which do not contain particles of a similar size to the platelets. Repeat measurements are taken after controlled agitation with sir to render the platelets invisible to an automated analyser. The difference between the population from the two measurements provides a measure of the number of platelets, their age and physiological properties. In a whole blood sample, only the platelets will disappear. For instance, if the cell counts before and after agitation with air do not differ, then there are no platelets in the suspension.
  • Shaking with glass beads has a small effect on the platelet count and may therefore be preferable to shaking with air or some other gas for initial sample mixing when the aim is to avoid platelet disappearance.
  • the mechanical effect of shaking was further differentiated from the effect of air admixture by continuously withdrawing aliquots from a conical flask when it contained no air (being full of the blood suspension) until it was empty containing nothing but air. All the while the blood suspension was continuously agitated with a stirring bar. The platelet count remained constant so long as the flask was full, but once the sample/air ratio fell below a half, the platelets began to disappear and did so in direct proportion to the volume of air in the flask.
  • the platelets In the absence of air, the platelets do not disappear appreciably within seconds as they do in the presence of air. Thus counting the platelets against duration or intensity of agitation with air (or its components), will induce them to diminish or completely disappear but bacteria, fragments or any other element that may be found in the blood with neither diminish nor disappear.

Abstract

A method of determining a measure of the number of platelets in a cell suspension containing platelets. The number of small particles in the suspension is counted. The suspension is agitated in the presence of a gas. The number of small particles in the suspension after agitation is counted. The two counts are compared to obtain a measure of the number of platelets.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a method of analysing a sample of free cells, in particular blood cells. [0001]
  • BACKGROUND TO THE INVENTION
  • Automated blood analysers which count and size blood cells, represent a huge advance in the field of clinical medicine, but retain some drawbacks. They are inherently incapable of differentiating like sized particles. While the automated count may be correct in terms of the total number of particles, traditional methods do not count small red cells, parasites or bits of cells as platelets. Anyone in need of good quality platelet counts is well advised to travel to Africa or Asia which, having few automated blood analysers, provide better quality complete blood counts because manual methods of counting avoid several errors which are common concomitants of automated sizing and counting instruments. Errors in counting platelets have serious consequences for the patient as they may result in unnecessary tests, inappropriate treatment, or misdiagnosis. The known causes of spurious low platelet counts are EDTA dependent clumping, cold platelet agglutination, platelet satellitism and the presence of like sized particles which are not platelets. [0002]
  • All haematology texts, laboratories and manufacturers have been aware of the inaccuracies of automated platelet counts for many years and advise a manual inspection of a blood film for every patient with an abnormal platelet count, which is the practice in most haematology laboratories. Currently manufacturers are attempting to reduce errors by detecting light refraction (since platelets are more refractile) or by detecting stains applied to platelets before they reach the sensor. The practice of manual verification whenever the platelet measurements all outside the normal range is comforting to the patient but expensive for the laboratories. However, hitherto, there was no method of alerting labs of the need for manual verification for patients with high platelet counts that erroneously fell inside the normal range. Thus automated platelet counts are of limited value when platelet counts are low, they are of uncertain value when the counts are normal, and are not entirely secure when the counts are elevated (thrombocytosis). [0003]
  • As will be discussed below, the applicants have discovered that there are other small particles, cell fragments, which are also not detected and properly distinguished by existing automated blood cell analyzers. The importance of cell friability or the generation of cell fragments has hitherto not been recognised. [0004]
  • SUMMARY OF THE INVENTION
  • According to one aspect of the present invention, there is provided a method of determining a measure of the number of platelets in a cell suspension containing platelets, the method comprising the steps of: counting the number of small particles in the suspension; agitating the suspension in the presence of a gas; counting the number of small particles in the suspension after agitation; and comparing the two counts to obtain a measure of the number of platelets. [0005]
  • The method of the invention differentiates platelets from other small particles exploiting a simple physiological property and removes spuriously low automated platelet counts. The accurate measurement of platelet number and function is of great consequence to a patient's health. Aside from bleeding to death from thrombocytopenia (insufficient platelets), platelets are risk components of strokes, heart attacks, and inflammation, and are important elements in the growth of epithelial malignancies and metastases. [0006]
  • All red cells are very sensitive to osmotic stress, and most cells are sensitive to mechanical stress. It has been found that platelets are relatively insensitive to mechanical and osmotic stress except when exposed to contact with air. Platelet suspensions alter their properties upon exposure to air, or its component gases to a greater extent if they are simultaneously stressed. By carefully controlling the handling of platelets before and during testing, by eliminating or regulating a suspension's exposure to air, more accurate platelet counts can be obtained. By intentionally exposing platelets to air while subjecting them to stress any induced change in the platelet population can be recorded. Because existing methods ignore the effect of air, they are inducing errors in their platelet counts. [0007]
  • The methods described in WO 97/24598, WO 97/24599 and WO 97/24601 provide a way to measure the size, shape, and number of particles while the particles are simultaneously exposed to a variety of osmotic gradients. However, further information may be derived from this test by combining it with the present invention. For example, by testing a whole blood suspension under osmotic stress, and comparing the results to the same sample after mechanical agitation in the presence of air, the components of the sample population which are altered by mechanical agitation in the presence of air can be determined. Furthermore, the types and proportion of each type can be revealed in a single procedure. Thus, red cells, white cells, micro-spherocytes, and bacteria are uninfluenced by me agitation in the presence of air whereas platelets alone disappear. The advantage of this method is that in addition to explaining a way to differentiate and count platelets, it offers existing instruments a very simple method of increasing the accuracy of their counts. [0008]
  • In this application we also disclose a method of measuring cell friability since mechanical stress induces fragmentation in those cells. When cells are counted in cell counters, neither lysis nor fragmentation nor ghosts are induced. When cells are subjected to osmotic stress, they lyse and ghost or fragment or both. The addition of mechanical agitation enhances the effect and the addition of air into the agitated suspension further intensifies the effect. Thus, in order to differentiate between cell fragments and platelets, it has been found to be preferable to compare the count of small particles before and after agitation in the presence of air against osomolality. This process of inducing the nature of these small particles can be likened to the identification of an unknown fluid by raising its temperature; if it boils at 78° C. it is ethyl alcohol, if it boils at 100° C. it is water and at 357° C. it is mercury. [0009]
  • In order to provide quantative measures from the present invention, it is preferable to monitor at least one of the following: A) the air quantity in contact with the suspension, B) the intensity of agitation and C) the duration of agitation, and to relate this measured value to the difference between the two counts. [0010]
  • The small particles counted in the method of the invention include platelets, bacteria, cell fragments, and micro-spherocytes, which typically have a volume of 7-10 femtolitres. [0011]
  • According to another aspect of the present invention, a method of analysing a sample of free cells in vitro comprises applying a known or identifiable quantity of stress to the sample, measuring the sample before and after the application of stress to provide at least one reading from which quantitative information relating to the number of cell fragments in the sample caused by the applied stress can be determined, and relating this reading to the quantity of stress to provide an indication of cell friability. [0012]
  • When red cells die, they lose their contents, a process termed lysis. They are then transformed into either ghost cells or fragments depending, in part, on the cell's membrane properties, and in part on the provocation. Hitherto, this mechanism has been little recognised or understood. [0013]
  • The present invention is based on the realisation that if cells, such as blood cells, and in particular red cells, are stressed in vitro the relationship between the applied stress and fragmentation to the sample is characteristic for normal samples and for many diseases. Since some cells (platelets) produce no detectable fragments and some (red cells) produce a large number this method also provides a way of distinguishing between certain cell types. [0014]
  • Existing automated particle analysers are of limited use in detecting fragments as they cannot identify fragmentation that was cleared in vivo by increased phagocytosis, and when fragments were not phagocytosed, it cannot easily differentiate them from platelets, apoptotic bodies, micro-spherocytes, parasites and noise. There are many patients whose cells are fragmenting yet no fragments are detected by existing methods because the body's physiological clearing mechanism removes fragments as fast as they are produced. [0015]
  • The method of the present invention has been found to be remarkably good at identifying certain blood abnormalities because it detects patients whose cells fragment when stressed. Because applied stress affects red blood cell fragments and platelets differently, it is possible to distinguish between the two. This has not been possible in the prior art-particle counters because platelets and red blood cells fragments are usually not measured individually. In addition, as a sample can be tested before, during and after a stress has been applied, the induced effect provides an indication of the physiological fragmentation potential and the physiological removal rate. [0016]
  • The invention can be used to identify the age of population of cells since old cells fragment readily whereas new ones do not fragment readily. This may be useful in blood-banking, for instance, to destroy selectively a particular population of cells using a particular range of stresses, thereby prolonging the life of the unit by culling the old cells. [0017]
  • The applied stress can be mechanical, chemical, thermal, sonic, light, electric, electromagnetic, or any other means which induces membrane stress including in vitro aging of the cell sample. Preferably, the cells are subjected to an osmotic gradient. They may also be agitated by a stirring bar, by shaking vigorously, or by any other type of stress. More than one stress mechanism can be used at the same time if necessary. Indeed this may be beneficial in identifying certain abnormalities. [0018]
  • It is, however, preferable to apply a known stress, and more preferable to apply a range of stresses, which may be decreasing or haphazard, but is preferably increasing, so as to obtain a plot of the relationship between the number of red blood cell fragments and the applied stress. This range of stresses can be applied by varying duration and/or intensity, for example, by virtue of mechanically agitating the sample increasingly vigorously, by mechanically agitating the sample at a constant rate over an increasing period of time, by diluting the sample with a solution which gradually decreases in osmolality, or by any combination of these mechanisms. The latter approach can be carried out using the apparatus disclosed in WO 97/24529, which generates an osmolality gradient. [0019]
  • Characteristics providing the quantative information relating to the number of cell fragments include the detection of the fragments themselves, an alteration in the frequency distributions of multiple cell populations, an increase in the total particle count, a change in the concentration of intact cells, a change in the concentration of membrane or cytosolic parts, such as haemoglobin release, or other such phenomena related to induced cell fragmentation. [0020]
  • The step of counting the number of small particles is preferably done using a conventional commercially available particle counter, or using the apparatus disclosed in WO 97/24600. In both cases, the blood sample is caused to flow through a sensor, typically an aperture, where its size is detected optically, acoustically, thermally, electronically or by other means. In an impedance sensor, the response of the electrical field to the passage of the cells is recorded as a series of voltage pulses, the amplitude of each pulse being a function of cell fragment size and frequency. [0021]
  • In the absence of applied stress, existing instruments are unable to distinguish between platelets and, for instance, red cell fragments. As each different cell type has its own biochemical individuality and its own sensitivity to fragmentation, it is possible to use its response as an identifying property, identifying the cell type, sensitivity and pathology. For instance, platelets which are-similar in size to fragments, are differentiated from fragments as they respond differently when stressed. The differentiation and identification of fragments, platelets, ghost cells and other cell parts may be facilitated by using stains and dyes which selectively dye cell lines, or bond onto specific cell parts, for instance the inside and outside of the cell membrane or only stain the platelets. When a stress has been applied to a blood sample, as for example, in WO 97/24598, WO 97/24599 and WO 97/24601, it was performed to obtain accurate volume and other cell measurements by forcing cells to a known shape. The method disclosed herein induces cells to fragment and measures the result of fragmentation. This may be enhanced by, for instance, eliminating all particles except for the fragments of interest by setting the upper and lower threshold voltages to the size range of fragments, by facilitating fragmentation by applying heparin or other suitable chemicals in the chemical preparation of the sample and/or by allowing sufficient time for fragmentation to proceed. The induction, detection and quantification of fragments enhances the measures produced by WO 97/24598, WO 97/24599 and WO 97/24601 and other measures which may be altered by induced or existing fragments. [0022]
  • When using an electrical particle counter, the thresholds should be set low enough to detect cells down to a volume of almost 0 femtolitres. A threshold voltage of 0.08 mV has been found to work well with the existing apparatus. Other populations of particles may be eliminated electronically, digitally, mechanically, or by other means. [0023]
  • The commercially available particle counters and the device disclosed in WO 97/24600 can be used to provide adequate readings for the present invention. However, more accurate readings can be obtained if the size of the aperture in either device is reduced so that the ration of the cross section of the aperture to the mean cross section of the red blood cell fragments or platelets is substantially 4:1. [0024]
  • In conventional blood cell analysis techniques, it is usual to treat the sample with an anticoagulant, such as EDTA, prior to analysis. However, it tends to inhibit fragmentation. It has therefore been found preferable not to treat the sample with an anticoagulant or to use an anticoagulant which does not inhibit or promote fragmentation, such as heparin.[0025]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Examples of the present invention will now be described in detail with reference to the accompanying drawings, in which: [0026]
  • FIGS. [0027] 1 to 5 are frequency distributions indicating the profile of cell size measurement against increasing osmotic and mechanical stress for a number of cell samples.
  • DETAILED DESCRIPTION
  • Examples of results obtained using the method according to the present invention, will now be described with reference to FIGS. [0028] 1 to 5 of the accompanying drawings, which are frequency distributions indicating the profile of the cell size measurement against increasing stress for a sample of cells tested using the apparatus disclosed in WO 97/24529 and the electrode disclosed in WO 97/24600.
  • Such frequency distributions have previously been used, for example in WO 97/24598, WO 97/24599, and WO 97/24601, for example to provide indications of the cell permeability, osmolality and cell shape respectively of normal unfragmented red blood cells. [0029]
  • The samples tested were treated with heparin, mechanically agitated by stirring or shaking in air, then subjected to an osmotic gradient using the apparatus disclosed in WO 97/24529. [0030]
  • FIG. 1 is a blood sample from a healthy person. As the stress is increased from point A onwards, the cells begin to swell resulting in the gradual increase in mean cell size. At a certain osmolality the cell size can increase no more, and upon a further increase-in stress, the cells evacuate their contents to become “ghost cells” as shown at region B. These characteristics of cells yield diagnostic information which is useful alongside the techniques of the present invention. However, the present invention is unconcerned with these characteristics and is independent of them, but is instead concerned with the cells which appear along the baseline of the graph of FIG. 1. The nature of these small baseline cells can be differentiated by their distribution against osmotic stress, their distribution against mechanical stress and/or their response to contact with air. Platelets are uninfluenced by osmotic stress within the range tested (300-100 mOsm/Kg). However, fragments are strongly influenced by osmotic stress. They rarely appear without the provocation of lysis and become more numerous as lysis increases. Thus fragments vary inversely with osmolality. Mechanical stress has opposing effects on platelets and fragments, an influence that is intensified by concomitant exposure to air. It provokes the appearance of fragments but it induces the lysis of platelets rendering them invisible. [0031]
  • FIGS. [0032] 2A-F demonstrate that platelets are rendered invisible with progressive agitation in air (with respective agitation periods of 0, 1, 2, 6, 10 and 15 seconds). The signal along the base line in FIG. 2A is attributable to the presence of platelets since their frequency is approximately the same at all osmolalites, and since even 2 seconds of agitation in air induces almost complete disappearance (see FIG. 2C). The phenomenon cannot be attributed to platelet attachment to the red cells or white cells (satelitism) since FIGS. 3A-F shows the same phenomenon in a pure platelet suspension when no other cells types are present.
  • FIGS. [0033] 4A-E demonstrate the effect of mechanical agitation in air with time. As the agitation period proceeds going from 4A down to 4E the number of fragments generated increases. At the same time, platelets are rapidly made invisible (although it is difficult to see this in these particular Figures). FIGS. 5A-D demonstrate the platelet reduction in a whole blood sample on shaking with air. Such frequency distributions have previously been used, for example, in WO 97/24598, WO 97/24599, WO 97/24601.
  • The preferred method comprises measuring platelets, using existing automated particle counters, mixing and testing the sample in the absence of air. If some air is unavoidable, the surface area of the samples meniscus should be minimized to limit the effect on the sample or alternatively a gas which has no effect on the platelets should be used. This single measurement will provide an accurate count for all samples which do not contain particles of a similar size to the platelets. Repeat measurements are taken after controlled agitation with sir to render the platelets invisible to an automated analyser. The difference between the population from the two measurements provides a measure of the number of platelets, their age and physiological properties. In a whole blood sample, only the platelets will disappear. For instance, if the cell counts before and after agitation with air do not differ, then there are no platelets in the suspension. [0034]
  • We have measured platelets under a variety of experimental conditions: in pure platelet suspensions, in the presence of all other blood cell elements, in containers of glass, polystyrene and polypropylene, after exposure to varying surface areas in a thin film and by shaking with varying quantities of glass beads, after exposure to varying osmotic, mechanical, thermal, and sonic stress, and after mechanical agitation with air and nitrogen. [0035]
  • By measuring the platelet count against all these stresses, we have found conditions which render platelets electronically invisible, while other types of cells are unaltered or transformed but remain visible to automated analysers. Moreover the speed and characteristic of the disappearance is an indication of platelet health and function. [0036]
  • In all laboratories, prior to any analysis on any blood sample, the sample is first shaken to mix the cell types randomly with respect to each other and with the plasma. The agitation is continued during the process of analysis in automated instruments, and the cells are exposed to agitation in the presence of a variable amount of air, both deliberately and accidentally. [0037]
  • Indeed, many instruments use air bubbles as a way to separate each bolus of blood or clean the tubes and instrument conduits. [0038]
  • Shaking with glass beads has a small effect on the platelet count and may therefore be preferable to shaking with air or some other gas for initial sample mixing when the aim is to avoid platelet disappearance. The mechanical effect of shaking was further differentiated from the effect of air admixture by continuously withdrawing aliquots from a conical flask when it contained no air (being full of the blood suspension) until it was empty containing nothing but air. All the while the blood suspension was continuously agitated with a stirring bar. The platelet count remained constant so long as the flask was full, but once the sample/air ratio fell below a half, the platelets began to disappear and did so in direct proportion to the volume of air in the flask. In the absence of air, the platelets do not disappear appreciably within seconds as they do in the presence of air. Thus counting the platelets against duration or intensity of agitation with air (or its components), will induce them to diminish or completely disappear but bacteria, fragments or any other element that may be found in the blood with neither diminish nor disappear. [0039]
  • The method is useful in the following: [0040]
  • 1. IMPROVED DISEASE DIAGNOSIS. More accurate platelet counts will lead to better disease diagnosis and prognosis. [0041]
  • 2. EXISTING METHODS OF BLOOD TESTING. By using an inert gas, or eliminating air from the mixing, automated instruments will improve the accuracy and repeatability of platelet counting and sizing. [0042]
  • 3. A NEW MEASURE OF PLATELET HEALTH. By using this method, new information about platelet health is derived from their sensitivity to air and their rate of disappearance and reappearance. [0043]
  • 4. BLOOD COLLECTION. Currently Vacutainers (trade mark) (partial vacuum glass specimen tube) contain air, and more is sometimes admitted when the sample is smaller than required. [0044]

Claims (13)

1. A method of determining a measure of the number of platelets in a cell suspension containing platelets, the method comprising the steps of:
counting the number of small particles in the suspension;
agitating the suspension in the presence of a gas;
counting the number of small particles in the suspension after agitation; and,
comparing the two counts to obtain a measure of the number of platelets.
2. A method according to claim 1, in which the gas is air, or one or more of its constituent gases.
3. A method according to claim 1 or 2, in which one or more aliquots of the suspension are passed through a particle counter before the suspension is agitated to obtain a first count of the number of small particles and subsequently one or more other aliquots of the suspension are passed through a particle counter after agitation to obtain a second count of the number of small particles in the sample.
4. A method according to any preceding claim, in which the cell suspension is isotonic.
5. A method according to any preceding claim, in which small particles having a volume of at least 7 femtolitres are detected to obtain a count of the number of small particles in the suspension.
6. A method according to any preceding claim, in which the suspension is subjected to a series of alterations in osmolality and a count of the number of small particles in the suspension obtained at a number of different osmolalities.
7. A method according to any preceding claim, in which at least one of the air quantity in contact with the suspension, the intensity of agitation, and the duration of agitation, is measured.
8. A method of analysing a sample of free cells in vitro comprising the steps of:
applying a known or identifiable quantity of stress to the sample;
measuring the sample before and after the application of stress to provide at least one reading from which quantitative information relating to the number of cell fragments in the sample caused by the applied stress can be determined; and,
relating this reading to the quantity of stress to provide an indication of cell friability.
9. A method according to claim 8, in which the applied stress is at least one of the group consisting of mechanical, chemical, thermal, sonic, light, electric, electromagnetic, and an alteration in osmolality.
10. A method according to claim 8 or 9, in which a range of stresses are applied so as to obtain a plot of the relationship between the number of cell fragments and the applied stress.
11. A method according to claim 8 or 9, in which the sample is subjected to an osmotic gradient.
12. A method according to claim 10 or 11, in which measurements are made at a number of different osmolalities so as to obtain data describing the relationship between the number of cell fragments and the applied stress.
13. A method according to any of claims 8 to 12, in which detection thresholds used to count the number of particles are set sufficiently low to detect cells down to a volume of substantially zero femtolitres.
US10/329,608 1998-12-29 2002-12-26 Method of analysing a sample of free cells Abandoned US20030138871A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/329,608 US20030138871A1 (en) 1998-12-29 2002-12-26 Method of analysing a sample of free cells

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9828765.9A GB9828765D0 (en) 1998-12-29 1998-12-29 A method of testing a cell sample
GBGB9828765.9 1998-12-29
GBGB9910266.7A GB9910266D0 (en) 1999-05-04 1999-05-04 A method of analysing a sample of free cells
GBGB9910266.7 1999-05-04
GBGB9910267.5 1999-05-04
GBGB9910267.5A GB9910267D0 (en) 1999-05-04 1999-05-04 A method of determining the number of platelets in a cell suspension containing platelets
US09/623,186 US6699680B1 (en) 1998-12-29 1999-12-24 Method of determining a number of platelets
US10/329,608 US20030138871A1 (en) 1998-12-29 2002-12-26 Method of analysing a sample of free cells

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB1999/004428 Division WO2000039559A2 (en) 1998-12-29 1999-12-24 A method of analysing a sample of free cells
US09/623,186 Division US6699680B1 (en) 1998-12-29 1999-12-24 Method of determining a number of platelets

Publications (1)

Publication Number Publication Date
US20030138871A1 true US20030138871A1 (en) 2003-07-24

Family

ID=27269605

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/623,186 Expired - Lifetime US6699680B1 (en) 1998-12-29 1999-12-24 Method of determining a number of platelets
US10/329,608 Abandoned US20030138871A1 (en) 1998-12-29 2002-12-26 Method of analysing a sample of free cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/623,186 Expired - Lifetime US6699680B1 (en) 1998-12-29 1999-12-24 Method of determining a number of platelets

Country Status (6)

Country Link
US (2) US6699680B1 (en)
EP (2) EP1058830B1 (en)
JP (1) JP4402301B2 (en)
AU (1) AU732426B2 (en)
NZ (1) NZ506590A (en)
WO (1) WO2000039559A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476546B2 (en) 2004-11-15 2009-01-13 University Of North Dakota Method for single oxygen atom incorporation into digested peptides using peptidases
CN111033256A (en) * 2017-09-05 2020-04-17 深圳迈瑞生物医疗电子股份有限公司 Alarming method of platelet aggregation sample, blood cell analyzer and storage medium
CN111656161A (en) * 2018-04-28 2020-09-11 深圳迈瑞生物医疗电子股份有限公司 Sample analyzer abnormity warning method, system and storage medium

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058830B1 (en) * 1998-12-29 2012-07-11 Ian Basil Shine A method of analysing a sample of free cells
US7822276B2 (en) * 2005-02-17 2010-10-26 Iris International, Inc. Method and apparatus for analyzing body fluids
JP5058320B2 (en) * 2010-09-16 2012-10-24 シスメックス株式会社 Blood imaging apparatus and blood imaging method

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502412A (en) * 1967-10-16 1970-03-24 Abbott Lab Method and apparatus for measuring osmotic fragility of red blood cells by constantly reducing the concentration of the saline solution suspending the cells
US3851246A (en) * 1973-11-26 1974-11-26 Us Navy Method of predicting the post transfusion viability of preserved erythrocytes and other similar cells
US4081340A (en) * 1974-02-02 1978-03-28 Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung Method of and device for increasing the permeability of the skin of cells of living beings
US4240027A (en) * 1978-08-31 1980-12-16 The United States Of America As Represented By The Secretary Of The Army Electromagnetic method for the noninvasive analysis of cell membrane physiology and pharmacology
US4271001A (en) * 1978-03-23 1981-06-02 Asahi Kasei Kogyo Kabushiki Kaisha Apparatus for measuring membrane characteristics of vesicles
US4298836A (en) * 1979-11-23 1981-11-03 Coulter Electronics, Inc. Particle shape determination
US4374644A (en) * 1981-04-06 1983-02-22 Coulter Electronics, Inc. Blood cell volume monitoring
US4375615A (en) * 1979-04-20 1983-03-01 Becton Dickinson And Company Apparatus for counting particles in a liquid suspension
US4521729A (en) * 1982-04-28 1985-06-04 Holger Kiesewetter Instrument for measuring the deforming capacity of red blood corpuscles
US4535284A (en) * 1981-07-10 1985-08-13 Coulter Electronics, Inc. High and low frequency analysis of osmotic stress of cells
US4791355A (en) * 1986-10-21 1988-12-13 Coulter Electronics Inc. Particle analyzer for measuring the resistance and reactance of a particle
US4810963A (en) * 1984-04-03 1989-03-07 Public Health Laboratory Service Board Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance
US5006460A (en) * 1988-05-26 1991-04-09 Pantox Corporation Method for measuring DNA damage in single cells
US5308757A (en) * 1990-08-08 1994-05-03 Hitachi, Ltd. Biological cell treatment method and apparatus
US5464752A (en) * 1987-03-13 1995-11-07 Coulter Corporation Automated analyzer for screening cells or formed bodies for enumeration of populations expressing selected characteristics
US5532139A (en) * 1992-10-30 1996-07-02 Micro-Med, Inc. Micro lysis-analysis process to measure cell characteristics and diagnose diseases
US5700632A (en) * 1994-05-27 1997-12-23 Methodist Hospital Of Indiana General method to quickly remove cryoprotectants from animal cells while maintaining viability
US5856665A (en) * 1991-07-12 1999-01-05 Jeffrey H. Price Arc lamp stabilization and intensity control for imaging microscopy
US6218190B1 (en) * 1995-12-29 2001-04-17 Thomas Adam Shine Method for testing a cell suspension
US6699680B1 (en) * 1998-12-29 2004-03-02 Ian Basil Shine Method of determining a number of platelets

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3606539A (en) * 1968-11-13 1971-09-20 American Optical Corp Apparatus and method for measuring osmotic fragility of red blood cells
CA988319A (en) 1973-10-11 1976-05-04 Tomas Hirschfeld System for differentiating particles
IT1105662B (en) * 1978-09-07 1985-11-04 Salus Istituto Diagnostico Di EQUIPMENT FOR STUDYING AND PHENOMENA OF HEMOCOAGULATION AND PLATE AGGREGATION
US4664796A (en) * 1985-09-16 1987-05-12 Coulter Electronics, Inc. Flux diverting flow chamber for high gradient magnetic separation of particles from a liquid medium
JP2565844B2 (en) * 1992-02-07 1996-12-18 アボツト・ラボラトリーズ Accurate counting of heterogeneous cell populations under lysis conditions and grading for sensitivity
GB9526653D0 (en) * 1995-12-29 1996-02-28 Shine Thomas A Fluid delivery device
GB9526684D0 (en) 1995-12-29 1996-02-28 Shine Thomas A Method for testing a cell sample
DE69635391T2 (en) * 1995-12-29 2006-08-03 Basil Ian Shine Method for examining a cell sample
GB9526652D0 (en) 1995-12-29 1996-02-28 Shine Thomas A Electrode assembly

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502412A (en) * 1967-10-16 1970-03-24 Abbott Lab Method and apparatus for measuring osmotic fragility of red blood cells by constantly reducing the concentration of the saline solution suspending the cells
US3851246A (en) * 1973-11-26 1974-11-26 Us Navy Method of predicting the post transfusion viability of preserved erythrocytes and other similar cells
US4081340A (en) * 1974-02-02 1978-03-28 Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung Method of and device for increasing the permeability of the skin of cells of living beings
US4271001A (en) * 1978-03-23 1981-06-02 Asahi Kasei Kogyo Kabushiki Kaisha Apparatus for measuring membrane characteristics of vesicles
US4240027A (en) * 1978-08-31 1980-12-16 The United States Of America As Represented By The Secretary Of The Army Electromagnetic method for the noninvasive analysis of cell membrane physiology and pharmacology
US4375615A (en) * 1979-04-20 1983-03-01 Becton Dickinson And Company Apparatus for counting particles in a liquid suspension
US4298836A (en) * 1979-11-23 1981-11-03 Coulter Electronics, Inc. Particle shape determination
US4374644A (en) * 1981-04-06 1983-02-22 Coulter Electronics, Inc. Blood cell volume monitoring
US4535284A (en) * 1981-07-10 1985-08-13 Coulter Electronics, Inc. High and low frequency analysis of osmotic stress of cells
US4521729A (en) * 1982-04-28 1985-06-04 Holger Kiesewetter Instrument for measuring the deforming capacity of red blood corpuscles
US4876504A (en) * 1984-04-03 1989-10-24 Public Health Laboratory Service Board Apparatus for investigating the condition of a bacteria containing suspension through frequency profile of electrical admittance
US4810963A (en) * 1984-04-03 1989-03-07 Public Health Laboratory Service Board Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance
US4791355A (en) * 1986-10-21 1988-12-13 Coulter Electronics Inc. Particle analyzer for measuring the resistance and reactance of a particle
US5464752A (en) * 1987-03-13 1995-11-07 Coulter Corporation Automated analyzer for screening cells or formed bodies for enumeration of populations expressing selected characteristics
US5006460A (en) * 1988-05-26 1991-04-09 Pantox Corporation Method for measuring DNA damage in single cells
US5308757A (en) * 1990-08-08 1994-05-03 Hitachi, Ltd. Biological cell treatment method and apparatus
US5856665A (en) * 1991-07-12 1999-01-05 Jeffrey H. Price Arc lamp stabilization and intensity control for imaging microscopy
US5532139A (en) * 1992-10-30 1996-07-02 Micro-Med, Inc. Micro lysis-analysis process to measure cell characteristics and diagnose diseases
US5700632A (en) * 1994-05-27 1997-12-23 Methodist Hospital Of Indiana General method to quickly remove cryoprotectants from animal cells while maintaining viability
US6218190B1 (en) * 1995-12-29 2001-04-17 Thomas Adam Shine Method for testing a cell suspension
US6699680B1 (en) * 1998-12-29 2004-03-02 Ian Basil Shine Method of determining a number of platelets

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476546B2 (en) 2004-11-15 2009-01-13 University Of North Dakota Method for single oxygen atom incorporation into digested peptides using peptidases
CN111033256A (en) * 2017-09-05 2020-04-17 深圳迈瑞生物医疗电子股份有限公司 Alarming method of platelet aggregation sample, blood cell analyzer and storage medium
US11402370B2 (en) 2017-09-05 2022-08-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Alarming method for platelet aggregation sample, blood cell analyzer and storage medium
CN111656161A (en) * 2018-04-28 2020-09-11 深圳迈瑞生物医疗电子股份有限公司 Sample analyzer abnormity warning method, system and storage medium
US11781983B2 (en) 2018-04-28 2023-10-10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Alarm method, system and storage medium for abnormalities of sample analyzer

Also Published As

Publication number Publication date
AU1881700A (en) 2000-07-31
US6699680B1 (en) 2004-03-02
EP2322910A2 (en) 2011-05-18
EP2322910A3 (en) 2012-02-01
EP2322910B1 (en) 2019-03-13
EP1058830B1 (en) 2012-07-11
JP4402301B2 (en) 2010-01-20
NZ506590A (en) 2002-10-25
WO2000039559A2 (en) 2000-07-06
JP2002533712A (en) 2002-10-08
WO2000039559A3 (en) 2000-11-09
AU732426B2 (en) 2001-04-26
EP1058830A1 (en) 2000-12-13

Similar Documents

Publication Publication Date Title
Kachel et al. Fluvo-metricell, a combined cell volume and cell fluorescence analyzer.
Bain et al. Basic haematological techniques
EP0515099B1 (en) Apparatus for analyzing cells in urine
US4747685A (en) Biological microparticle inspection apparatus
Bayliss et al. Detecting fetomaternal hemorrhage: a comparison of five methods
KR970048449A (en) Highly sensitive and accurate automated method for identifying and quantifying platelets and determining platelet activation using whole blood samples
US5197017A (en) Potentiophotometric fibrinogen determination
SE442347B (en) COMPOSITION FOR TESTING BIOLOGICAL TABLES OR SCIENCES CONTAINING A DNA INTERACTIVE SUBSTANCE AND A SUBSTITUTING SUBJECT, AND A METHOD OF USING THE COMPOSITION
US4535284A (en) High and low frequency analysis of osmotic stress of cells
US6699680B1 (en) Method of determining a number of platelets
JP2002005925A (en) Measuring method of crushed erythrocyte
US6422065B1 (en) Method for testing a cell sample
Chiron et al. The GEN. S: a fortuitous finding of a routine screening test for hereditary spherocytosis
Siekmeier et al. Determination of reticulocytes: three methods compared
Cantinieaux et al. Accurate flow cytometric measurement of bacteria concentrations
Dumoulin-Lagrange et al. Evaluation of automated platelet counters for the enumeration and sizing of platelets in the diagnosis and management of hemostatic problems
Carlan et al. The effect of maternal blood contamination on the TDx-FLM II assay
JP4087446B2 (en) Methods for testing cell suspensions
CA2358920C (en) A method of testing a cell sample
AU2021303836A1 (en) Method for evaluating the metabolic activity of a non-cancer cell
Kumari et al. ANALYSIS OF PLATELET INDICES AND ITS PREDICTIVE VALUE IN DIAGNOSIS OF THROMBOCYTOPENIA
Blume et al. An instrumental method for the detection of erythrocyte agglutination
Holm et al. Flow Cytometry

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE